Avid Bioservices Inc (CDMO)

[purpledawgs]

Jake, how does this quote from Halo’s 2/21/19 10K affect CDMO?

“Product sales, net decreased in 2018 compared to 2017, primarily due to a decrease in the sales of bulk rHuPH20 to Roche and Baxalta, partially offset by an increase in sales of bulk rHuPH20 to Janssen. As previously anticipated, Roche and Baxalta are depleting their existing inventory of rHuPH20 ahead of planned transitions to new manufacturing facilities, which resulted in lower bulk rHuPH20 product sales during 2018.”

Are Roche and Baxalta going to manufacture rHuPH20 internally? Doesn’t that limit Avis’s piece of the manufacturing business?

PD